Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Article
in En
| MEDLINE
| ID: mdl-36240755
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2022
Document type:
Article
Affiliation country: